

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Imatinib ni umuti w'indwara ya kanseri ugamije guhagarika proteyine zihariye zifasha selile za kanseri gukura no kwiyongera. Ikoreshwa cyane mu kuvura ubwoko bumwe bwa kanseri y'amaraso na tumo zimwe na zimwe zidakunze kuboneka, igaha icyizere abarwayi bashobora kuba batari bafite uburyo bwo kuvurwa neza mbere.
Uyu muti ugaragaza intambwe ikomeye mu kuvura kanseri kuko ugamije selile za kanseri neza kurusha imiti gakondo ya chimiothérapie. Aho kugaba ibitero ku selile zose zikora vuba, imatinib yibanda kuri proteyine zidasanzwe zituma kanseri zihariye zikura.
Imatinib ni ubwoko bw'umuti wa kanseri witwa tyrosine kinase inhibitor. Iherereye mu cyiciro cy'imiti izwi nka imiti ivura igamije, bivuze ko igamije proteyine zihariye zigira uruhare mu mikurire ya selile za kanseri.
Uyu muti ukora uhagarika enzymes yitwa tyrosine kinases itanga ibimenyetso bibwira selile za kanseri kwiyongera. Tekereza kuri izi enzymes nk'ibishushanyo byaka bituma kanseri ikura - imatinib mu by'ukuri ihindura ibyo bishushanyo ikabishyira ku mwanya wa "kuzimya".
Bitandukanye na chimiothérapie gakondo igira ingaruka ku bwoko bwinshi bwa selile mu mubiri wawe, imatinib yagenewe kuba itoranya cyane. Ubu buryo bugamije akenshi butera ingaruka nke ugereranije n'ubuvuzi gakondo bwa kanseri.
Imatinib ikoreshwa cyane mu kuvura kanseri y'amaraso yitwa chronic myeloid leukemia (CML), ubwoko bwa kanseri y'amaraso igira ingaruka ku turemangingo tw'amaraso twera. Ikoreshwa kandi mu kuvura tumo zimwe na zimwe ziboneka mu gifu (GISTs), ari tumo zidakunze kuboneka zishobora kwigaragaza mu nzira y'igogora.
Ku barwayi ba CML, imatinib yahinduye icyari ikibazo giteye ubwoba cyane mu buzima, ikigihindura indwara idakira igenda ifashwa na benshi. Uyu muti ushobora gufasha kugenzura kanseri, kugabanya ibimenyetso, no kunoza cyane imibereho myiza.
Muganga wawe ashobora no kukwandikira imatinib kubera izindi ndwara zitamenyerewe, harimo ubwoko bumwe bwa kanseri ya leukemia ya lymphoblastic (ALL) na zimwe mu ndwara zitamenyerewe zo mu maraso. Izi nshingano zishingiye ku bimenyetso byihariye bya genetike selile zawe za kanseri zifite.
Imatinib ikora yibanda ku poroteyine idasanzwe yitwa BCR-ABL iboneka muri selile nyinshi za CML. Iyi poroteyine ikora nk'ikintu cyangiritse gihora cyatswe "kuri", gihora kibwira selile za kanseri gukura no kwigabanya.
Iyo ufata imatinib, yifatanya n'iyi poroteyine idasanzwe ikabuza ibikorwa byayo. Ibi bituma selile za kanseri zitabona ibimenyetso bakeneye kugirango byororoke bitagira uko bikorwa.
Uyu muti ufashwe nk'ukomeye ku rugero rwo kuvura kanseri. Nubwo akenshi yihanganirwa neza kurusha imiti ya kera ya chemotherapy, ni umuti ukomeye ugomba gukurikiranwa neza n'ikipe yawe y'ubuvuzi.
Kubera ibibyimba bya GIST, imatinib ikora ibuza poroteyine itandukanye yitwa KIT, ifasha ibi byibyimba gukura. Mu kubuza iyi poroteyine, uyu muti ushobora gufasha kugabanya ibibyimba cyangwa kubibuza gukura.
Fata imatinib nk'uko muganga wawe abitegeka, akenshi rimwe cyangwa kabiri ku munsi hamwe n'ibiryo n'ikirahure kinini cy'amazi. Kuyifata hamwe n'ibiryo bifasha kugabanya indwara zo mu nda, zikaba ari zimwe mu ngaruka zikunze kugaragara.
Mimina ibinini byose - ntukoreshe, uvunagure, cyangwa ubisye. Niba ugira ikibazo cyo kumira ibinini, ganira na muganga wawe kubyerekeye uburyo bwo kubishonga mu mazi cyangwa mu mutobe w'apulo.
Gerageza gufata umuti wawe ku gihe kimwe buri munsi kugirango bikufashe kwibuka no gukomeza urwego rumwe mu mubiri wawe. Abantu benshi basanga bifasha gufata imatinib hamwe na saftu cyangwa ifunguro rya nimugoroba.
Mugihe uvuga ibyo, irinda imbuto za pome na jus yazo mugihe ufata imatinib, kuko bishobora kubangamira uburyo umubiri wawe ukoresha imiti. Iyi mikoranire irashobora gutuma umuti udakora neza cyangwa ukongera ingaruka mbi.
Abantu benshi bafite CML bakeneye gufata imatinib igihe kirekire, akenshi imyaka myinshi cyangwa itagira iherezo. Umuti ukora igihe cyose ukomeje kuwufata, ariko kuwuhagarika akenshi bituma kanseri igaruka.
Muganga wawe azakurikiza uko witwara ku buvuzi binyuze mu igeragezwa ry'amaraso risanzwe n'izindi nyandiko. Izi igeragezwa bifasha kumenya neza niba umuti ukora neza kandi niba hariho impinduka zikenewe.
Ku barwayi ba GIST, igihe cyo kuvurwa giterwa n'ibintu bitandukanye, harimo uko igituntu cyitwara neza niba warabazwe. Abantu bamwe barashobora kuwufata igihe runaka, mugihe abandi bashobora gukenera kuvurwa igihe kirekire.
Ntuzigere uhagarika gufata imatinib utabanje kubiganiraho na muganga wawe. Guhagarika umuti ako kanya bishobora gutera kanseri kwihuta, n'iyo wumva umeze neza.
Kimwe n'indi miti yose, imatinib irashobora gutera ingaruka mbi, nubwo atari buri wese uzazibona. Ingaruka mbi nyinshi zirashobora gucungwa kandi zikunda gukira uko umubiri wawe wimenyereza umuti.
Ingaruka mbi zisanzwe ushobora guhura nazo zirimo isesemi, impiswi, kubabara imitsi, no kubika amazi bishobora gutera kubyimba mu maguru yawe, mu birenge, cyangwa hafi y'amaso yawe. Ibi bimenyetso akenshi biba byoroheje kugeza hagati kandi akenshi bikira uko igihe kigenda.
Dore ingaruka mbi zikunze kuvugwa n'abarwayi:
Inshuti nyinshi z'izi ngaruka zishobora guhangana n'ubufasha, impinduka mu mirire, cyangwa imiti yongereweho niba bibaye ngombwa. Itsinda ryawe ry'ubuvuzi rishobora gutanga ingamba zo gufasha kugabanya izi ngaruka.
Zimwe mu ngaruka zitamenyerewe ariko zikomeye zisaba ubufasha bwihuse bw'ubuvuzi. Izi zirimo kubika amazi bikabije bigira ingaruka ku guhumeka kwawe, ibimenyetso by'ibibazo by'umwijima nk'uruhu cyangwa amaso y'umuhondo, kuva amaraso cyangwa gukomeretsa bidasanzwe, n'ububabare bukomeye mu nda.
Ingaruka zitamenyerewe ariko zikomeye zirimo ibibazo by'umutima, kwangirika gukomeye kw'umwijima, no kugabanuka gukomeye kw'umubare w'uturemangingo tw'amaraso bikongera ibyago byo kwandura. Muganga wawe azagenzura ibi binyuze mu bipimo by'amaraso bisanzwe no gusuzuma.
Ntugomba gufata imatinib niba ufite allergie kuri yo cyangwa kuri kimwe mu bigize. Bwira muganga wawe ibyerekeye allergie zose wigeze kugira ku miti, cyane cyane niba waragize allergie zikomeye.
Abantu bafite indwara ikomeye y'umwijima bashobora gukenera guhindura urugero rw'imiti cyangwa ntibashobora kuba abakandida bakwiriye ku kuvurwa na imatinib. Muganga wawe azasuzuma imikorere y'umwijima wawe mbere yo gutangira kuvurwa kandi abigenzure buri gihe.
Niba utwite cyangwa ufite umugambi wo gutwita, ganira ibi na muganga wawe ako kanya. Imatinib ishobora gukomeretsa umwana utaravuka, bityo gukoresha uburyo bwo kuboneza urubyaro neza ni ngombwa mugihe cyo kuvurwa ku bagabo n'abagore.
Ababyeyi bonka ntibagomba gufata imatinib, kuko umuti ushobora kwinjira mu mata kandi ugashobora gukomeretsa umwana wonka. Uburyo bwo kugaburira bundi bushobora kuganirwaho n'itsinda ryawe ry'ubuvuzi.
Imatinib izwi cyane ku izina ry'ubwoko rya Gleevec muri Leta Zunze Ubumwe z'Amerika na Glivec mu bindi bihugu byinshi. Aya ni amazina y'ubwoko bw'umwimerere yakozwe n'uruganda rukora imiti rwa Novartis.
Ubundi bwoko bwa imatinib ubu buraboneka kandi bwitwa gusa "imatinib" ikurikizwa n'izina ry'uruganda ruyikora. Ubu bwoko bwa imatinib burimo ibintu bikora kimwe kandi bikora kimwe n'umuti w'izina ry'ubwoko.
Farmasi yawe ishobora gusimbuza ubundi bwoko keretse muganga wawe asabye izina ry'ubwoko. Ubwoko bwombi bukora kimwe, nubwo abantu bamwe bashobora kugira ibyo bakunda bitewe n'uburambe bwabo ku ngaruka ziterwa n'umuti cyangwa uko bawihanganira.
Niba imatinib itagukundiye cyangwa ikagutera ingaruka zidakira, imiti myinshi isimbura iraboneka. Ibi birimo izindi tyrosine kinase inhibitors nka dasatinib, nilotinib, na bosutinib yo kuvura CML.
Ku barwayi bafite ubudahangarwa kuri imatinib, iyi miti mishya akenshi itanga uburyo bwo gusimbuza bukora neza. Buri muti ufite ingaruka ziterwa n'umuti zitandukanye, bityo guhindura birashobora gufasha niba ufite ibibazo byihariye.
Uburyo bwo guhitamo gusimbuza buterwa n'ibintu bitandukanye birimo ubwoko bwawe bwihariye bwa kanseri, imiti wakoresheje mbere, izindi ndwara, n'uko wihanganiye imatinib. Muganga wawe w'inzobere mu kuvura kanseri azagufasha kumenya uburyo bwiza bw'ikibazo cyawe.
Abantu bamwe bashobora kandi kuba bakwiriye izindi miti nko kwimura umushongi w'amagufa, nubwo ibi bikunze gukorerwa ibihe byihariye n'abarwayi bakiri bato.
Imatinib niwo muti wa mbere wari ugamije kuvura CML kandi ukomeza kuba umuti mwiza wa mbere ku barwayi benshi. Ifite amateka maremare y'umutekano n'ubushobozi, hamwe n'imyaka irenga 20 y'uburambe mu buvuzi.
Imiti mishya nka dasatinib na nilotinib ishobora gukora vuba ku barwayi bamwe kandi ishobora gufasha abantu batitabira imatinib. Ariko, bashobora kandi kugira ingaruka ziterwa n'umuti zitandukanye abantu bamwe basanga bigoye.
Umuti "mwiza" utandukana ku muntu ku muntu bitewe n'ibintu nk'imyaka, izindi ndwara, uko wihanganira ingaruka ziterwa n'umuti, n'uko kanseri yitwara ku buvuzi. Muganga wawe azatekereza kuri ibyo byose igihe agushakira umuti.
Abantu benshi baritwara neza cyane ku imatinib nk'umuti wabo wa mbere kandi bakomeza kuwufata imyaka myinshi batagomba kuwuhindura. Ikintu cy'ingenzi ni ukubona umuti ukora neza ku miterere yawe yihariye n'imibereho yawe.
Rimwe na rimwe imatinib ishobora gutera ibibazo by'umutima, harimo no kubika amazi bishobora kuremerera umutima. Niba ufite indwara z'umutima, muganga wawe azakugenzura cyane kandi ashobora kugusaba ibizamini by'imikorere y'umutima mbere na nyuma yo kuvurwa.
Abantu benshi bafite ibibazo by'umutima barashobora gufata imatinib neza, ariko bakeneye kugenzurwa by'umwihariko. Umuganga w'umutima wawe n'umuganga w'indwara ya kanseri bazakorana kugira ngo barebe ko uwo muti ari mwiza kuri wowe.
Niba ufata imatinib nyinshi ku buryo butunguranye kuruta uko byategetswe, vugana na muganga wawe cyangwa ikigo gishinzwe kurwanya uburozi ako kanya. Ntukategere ibimenyetso, kuko kubona inama z'ubuvuzi vuba ni ingenzi.
Kufata imatinib nyinshi bishobora kongera ibyago byo kugira ingaruka zikomeye. Itsinda ryawe ry'ubuvuzi rishobora kwifuza kukugenzura cyane cyangwa gufata ingamba zihariye zo gukumira ibibazo.
Niba wibagiwe doze kandi bikaba bitarenze amasaha 12 uhereye ku gihe cyari giteganyijwe, yifate uko ubyibutse vuba. Niba hafi ya doze yawe itaha, reka iyo doze wibagiwe ukomeze gahunda yawe isanzwe.
Ntuzigere ufata doze ebyiri icyarimwe kugira ngo usubize iyo wibagiwe. Ibi bishobora kongera ibyago byo kugira ingaruka ziterwa n'umuti utagize akamaro.
Reka gukoresha imatinib gusa igihe muganga wawe akubwiye byeruye kubikora. N'iyo wumva umeze neza rwose kandi ibizamini byawe by'amaraso bisa nkibisanzwe, guhagarika imiti udafashijwe na muganga bishobora gutuma kanseri yongera kugaruka.
Abantu bamwe bashobora kuba bakwiriye gukoresha imiti idakoreshwa nyuma y'imyaka yo kuvurwa neza, ariko iki cyemezo gisaba isuzuma ryitondewe n'ikurikiranwa rikomeje n'ikipe yawe y'ubuvuzi.
Imiti myinshi irashobora gufatwa neza hamwe na imatinib, ariko imwe irashobora guhura kandi igahindura uburyo ikora neza. Buri gihe bwire muganga wawe na farumasiye ibijyanye n'imiti yose, ibyongerera imbaraga, n'ibicuruzwa by'ibyatsi urimo gufata.
Imiti imwe isanzwe ihura na imatinib irimo imiti imwe ya kanseri, imiti ivura ibibazo byo gufatwa, na antibiyotike zimwe. Ikipe yawe y'ubuvuzi izasuzuma imiti yawe yose kugirango yemeze ko ifatwa ryose rifite umutekano.
Get clear medical guidance
on symptoms, medications, and lab reports.